Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization. 2010

Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
Department of Ophthalmology and the Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam National University, Chonnam National University Medical School and Hospital, 8 Hak-dong, Gwangju, Korea. kcyoon@jnu.ac.kr

OBJECTIVE To report a case of recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization. METHODS A 69-year-old man who had lipid keratopathy with corneal neovascularization secondary to herpes simplex keratitis in the right eye and who was treated with topical steroid received photodynamic therapy with verteporfin. Six neovascular areas in the cornea were treated consecutively to occlude new vessels and reduce the risk of allograft rejection after subsequent keratoplasty. RESULTS Three days after verteporfin photodynamic therapy, there was evidence of vascular occlusion. However, a herpetic epithelial ulcer was detected in the cornea. Ten days after treatment, the lesion progressed to a geographic ulcer. After topical and systemic acyclovir treatment, the lesion healed. Five months after treatment, penetrating keratoplasty and postoperative antiviral prophylaxis were performed. During a follow-up period of 12 months, the graft remained clear with visual acuity of 20/40. CONCLUSIONS Herpes simplex keratitis can recur after verteporfin photodynamic therapy for corneal neovascularization.

UI MeSH Term Description Entries
D008297 Male Males
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077362 Verteporfin A benzoporphyrin derivative that is used in PHOTOCHEMOTHERAPY to treat wet type MACULAR DEGENERATION. 18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo(b)porphine-9,13-dipropanoic acid monomethyl ester,BPD Verteporfin,BPD-MA,Benzoporphyrin Derivative Monoacid Ring A,Verteporphin,Visudyne
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014775 Virus Activation The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses. Prophage Excision,Prophage Induction,Virus Induction,Viral Activation,Activation, Viral,Activation, Virus,Activations, Viral,Activations, Virus,Excision, Prophage,Excisions, Prophage,Induction, Prophage,Induction, Virus,Inductions, Prophage,Inductions, Virus,Prophage Excisions,Prophage Inductions,Viral Activations,Virus Activations,Virus Inductions

Related Publications

Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
January 2012, Middle East African journal of ophthalmology,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
July 2003, Cornea,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
October 2009, Cornea,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
April 2011, Optometry (St. Louis, Mo.),
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
October 2006, American journal of ophthalmology,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
July 2003, Investigative ophthalmology & visual science,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
January 2016, Revista medica del Instituto Mexicano del Seguro Social,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
October 1983, American journal of ophthalmology,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
May 1983, American journal of ophthalmology,
Kyung-Chul Yoon, and Seong-Kyu Im, and Hong-Yong Park
February 1998, The British journal of ophthalmology,
Copied contents to your clipboard!